Spondyloarthritis & psoriatic arthritis
Screening Tools for Spondyloarthritis in Patients With Psoriasis, Uveitis, and Inflammatory Bowel Disease: A Scoping Review
Authors' conclusion
Our results highlight the heterogeneity and limitations of existing SpA screening tools. Although these tools show promise for use within a specific target population, none are generalizable to all patients with extramusculoskeletal manifestations at risk of SpA.
Study context
- Population
- Patients with psoriasis, uveitis or inflammatory bowel disease (IBD) at risk of undiagnosed spondyloarthritis (SpA); PubMed, Embase and Web of Science searched from inception to January 202213 PsA, 2 uveitis and 3 IBD SpA screening tools
- Outcome
- SpA screening tools identified and their performance
Methodological detailsPRISMA guidelines
- PRISMA guidelines
Main finding
As reported in the abstract
- Screening tools for PsA in psoriasis
- 13
- SpA screening tools for uveitis
- 2
- SpA screening tools for IBD
- 3
- Average completion time
- less than five minutes
Original publication
Screening Tools for Spondyloarthritis in Patients With Psoriasis, Uveitis, and Inflammatory Bowel Disease: A Scoping Review. Arthritis Care Res (Hoboken). Published 28 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →